Skip directly to site content Skip directly to page options Skip directly to A-Z link Skip directly to A-Z link Skip directly to A-Z link
Volume 21, Number 10—October 2015

Epidemiology of Lyme Disease, Nova Scotia, Canada, 2002–2013

Todd F. HatchetteComments to Author , B. Lynn Johnston, Emily Schleihauf, Angela Mask, David Haldane, Michael Drebot, Maureen Baikie, Teri Cole, Sarah Fleming, Richard Gould, and Robbin Lindsay
Author affiliations: Nova Scotia Health Authority, Halifax, Nova Scotia, Canada (T.F. Hatchette, B.L. Johnston, D. Haldane); Dalhousie University, Halifax (T.F. Hatchette, B.L. Johnston, D. Haldane); Public Health Agency of Canada, Ottawa, Ontario, Canada (E. Schleihauf, A. Mask); Public Health Agency of Canada, Winnipeg, Manitoba, Canada (M. Drebot, R. Lindsay) Government of Nunavut, Iqaluit, Nunavut, Canada (M. Baikie); Nova Scotia Department of Health and Wellness, Halifax (T.J. Cole, S. Fleming); York Region Public Health, Newmarket, Ontario, Canada (R. Gould)

Main Article

Table 3

Characteristics of reported LD in 13 hospitalized patients, Nova Scotia Canada, 2002–2013*

Characteristic No. (%)
M 10 (76.9)
3 (23.1)
Age group, y
0–9 2 (15.4)
10–19 2 (15.4)
20–29 2 (15.4)
30–39 2 (15.4)
40–49 1 (7.7)
50–59 1 (7.7)
60–69 1 (7.7)
70–79 1 (7.7)
1 (7.7)
Rash, any reported 4 (30.8)
Influenza-like illness 9 (69.2)
EM, physician-diagnosed 4 (30.8)
Brief recurrent joint swelling 2 (15.4)
Bell palsy 3 (23.1)
Any nervous system sign or symptom 2 (15.4)
Cardiovascular system signs 2 (15.4)

*EM, erythema migrans; LD, Lyme disease.
†More than 1 symptom might be reported per case-patient. Rash, any reported, includes EM. Cardiovascular system signs include atrioventricular block, mycarditis, other.

Main Article

Page created: September 22, 2015
Page updated: September 22, 2015
Page reviewed: September 22, 2015
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.